SIMBRINZA
SIMBRINZA
Approved
DIN Number
02435411
Drug Class
Human
Market Date
Feb 17, 2015
Company
HC
novartis pharmaceuticals canada inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02435411
AIG Number0256350001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
S01EC54 BRINZOLAMIDE, COMBINATIONS
Product Specifications
Dosage FormSuspension
Route of AdministrationOphthalmic
AHFS Classification52:40.04
Health Canada Classification
ACTIVE INGREDIENTS (2)
BRIMONIDINE TARTRATEActive
Strength: 0.2 % / W/V
Monograph: BRIMONIDINE TARTRATE
BRINZOLAMIDEActive
Strength: 1 % / W/V
Monograph: BRINZOLAMIDE